Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?

Journal of the Neurological Sciences

Volumn 229-230, Issue , 2005, Pages 151-155

  Feigin, Valery ^a   Ratnasabapathy, Yogini ^a   Anderson, Craig ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Blood pressure lowering; Cognitive decline; Dementia; Drug studies; Meta analysis; Prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; CANDESARTAN HEXETIL; CAPTOPRIL; CHLORTALIDONE; ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; RESERPINE;

AGED; BLOOD PRESSURE REGULATION; COGNITIVE DEFECT; COMPREHENSION; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ERROR; DISEASE COURSE; DRUG EFFECT; HIGH RISK PATIENT; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELIABILITY; STROKE; SYSTOLIC HYPERTENSION;

EID: 14844291328     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.11.020     Document Type: Conference Paper

References (38)

1. J.C. de la Torre Alzheimer disease as a vascular disorder: nosological evidence Stroke 33 4 2002 1152 1162
2. I. Alafuzoff, S. Helisalmi, A. Mannermaa, and H. Soininen Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia Ann. N. Y. Acad. Sci. 903 2000 244 251
3. P.B. Gorelick, T. Erkinjuntti, A. Hofman, W.A. Rocca, I. Skoog, and B. Winblad Prevention of vascular dementia Alzheimer Dis. Assoc. Disord. 13 Suppl. 3 1999 S131 S139
4. M.M. Breteler, M.L. Bots, A. Ott, and A. Hofman Risk factors for vascular disease and dementia Haemostasis 28 3-4 1998 167 173
5. I. Skoog Status of risk factors for vascular dementia Neuroepidemiology 17 1 1998 2 9
6. V. Feigin New developments in dementia Acta Neurol. Scand. 106 2002 11 12
7. F. van Kooten, and P.J. Koudstaal Epidemiology of post-stroke dementia Haemostasis 28 3-4 1998 124 133
8. F. Pasquier, H. Henon, and D. Leys Risk factors and mechanisms of post-stroke dementia Rev. Neurol. 155 9 1999 749 753
9. P.B. Gorelick Status of risk factors for dementia associated with stroke Stroke 28 2 1997 459 463
10. L.J. Launer, K. Masaki, H. Petrovitch, D. Foley, and R.J. Havlik The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study JAMA 274 23 1995 1846 1851
11. M.E. Farmer, S.J. Kittner, R.D. Abbott, M.M. Wolz, P.A. Wolf, and L.R. White Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study J. Clin. Epidemiol. 43 5 1990 475 480
12. C. Tzourio, C. Dufouil, P. Ducimetiere, and A. Alperovitch Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA study group. Epidemiology of vascular aging Neurology 53 9 1999 1948 1952
13. W.T. Longstreth, T.A. Manolio, A. Arnold, G.L. Burke, N. Bryan, and C.A. Jungreis Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the cardiovascular health study Stroke 27 8 1996 1274 1282
14. H. Holzgreve, and M. Middeke Treatment of hypertension in the elderly Drugs 46 Suppl. 2 1993 24 31
15. L. Kilander, H. Nyman, M. Boberg, L. Hansson, and H. Lithell Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men Hypertension 31 3 1998 780 786
16. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson 15-Year longitudinal study of blood pressure and dementia Lancet 347 9009 1996 1141 1145
17. I. Aboderin, and G. Venables Stroke management in Europe. Pan European consensus meeting on stroke management J. Intern. Med. 240 4 1996 173 180
18. J. Bogousslavsky Consensus in stroke management? BMJ 318 7177 1999 140 141
19. G.J. Hankey Future directions in stroke management Aust. Fam. Physician 20 11 1991 1627-30 1627-38
20. M. Eliasson The systematic review is the foundation of evidence based medicine. One of the most important contributions to clinical medicine of the past decade Lakartidningen 97 22 2000 2726 2728
21. E.M. Antman, J. Lau, B. Kupelnick, F. Mosteller, and I. Chalmers A comparison of results of meta-analysis of randomised control trials and recommendations of clinical experts. Treatment for myocardial infarction JAMA 268 1992 240 248
22. M. Egger Under the meta-scope: possibilities and limits of meta-analyses Schweiz. Med. Wochenschr. 128 48 1998 1893 1901
23. I. Chalmers, and D.G. Altman Systematic reviews First ed. 1995 BMJ Publishing Group London
24. L. Pagliaro Preparing and interpreting meta-analysis in clinical research Arch. Ital. Urol. Androl. 69 4 1997 217 225
25. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, W.H. Birkenhager, and M.R. Babarskiene Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial Lancet 352 9137 1998 1347 1351
26. H. Lithell, L. Hansson, I. Skoog, D. Elmfeldt, A. Hofman, and B. Olofsson The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial J. Hypertens. 21 2003 875 886
27. C. Tzourio, C. Anderson, N. Chapman, M. Woodward, B. Neal, and S. MacMahon Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch. Intern. Med. 163 9 2003 1069 1075
28. M. Di Bari, M. Pahor, L.V. Franse, R.I. Shorr, J.Y. Wan, and L. Ferrucci Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial Am. J. Epidemiol. 153 1 2001 72 78
29. J.M. Starr, L.J. Whalley, and I.J. Deary The effects of antihypertensive treatment on cognitive function: results from the HOPE study J. Am. Geriatr. Soc. 44 4 1996 411 415
30. M.J. Prince, A.S. Bird, R.A. Blizard, and A.H. Mann Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults [comment] BMJ 312 7034 1996 801 805
31. L.A. Stewart, and M.K. Parmar Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 341 8842 1993 418 422
32. C.L. Vale, J.F. Tierney, and L.A. Stewart Effects of adjusting for censoring on meta-analyses of time-to-event outcomes Int. J. Epidemiol. 31 1 2002 107 111
33. J. Lau, J.P. Ioannidis, and C.H. Schmid Summing up evidence: one answer is not always enough Lancet 351 9096 1998 123 127
34. L.A. Stewart, and M.J. Clarke Practical methodology of meta-analyses (overviews) using update individual patient data Stat. Med. 14 1995 2057 2079
35. J.P. Higgins, A. Whitehead, R.M. Turner, R.Z. Omar, and S.G. Thompson Meta-analysis of continuous outcome data from individual patients Stat. Med. 20 15 2001 2219 2241
36. M.J. Clarke, and L.A. Stewart Systematic reviews of randomized controlled trials: the need for complete data J. Eval. Clin. Pract. 1 2 1995 119 126
37. J.F. Tierney, M. Clarke, and L.A. Stewart Is there bias in the publication of individual patient data meta-analyses? Int. J. Technol. Assess. Health Care 16 2 2000 657 667
38. M. Pahor, G.W. Somes, L.V. Franse, R.I. Shorr, and W.B. Applegate Prevention of dementia: Syst-Eur trial Lancet 353 9148 1999 235 237